Diabetes mellitus, oxidative stress and advanced glycation endproducts;Diabète sucré, stress oxydant et produits, de glycation avancée

Annales Pharmaceutiques Francaises

Volumn 62, Issue 3, 2004, Pages 147-157

  Bonnefont Rousselot, D ^a   Beaudeux, J L ^a   Therond P ^a   Peynet, J ^a   Legrand, A ^a   Delattre, J ^a  

^a Institut de Psychologie   (France)

Author keywords

Antioxidants; Diabetes; Free radicals; Glycation; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; CELL RECEPTOR; DNA; FREE RADICAL; LIPOPROTEIN; OXIDIZING AGENT; POLYOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

AUTOOXIDATION; CHRONIC DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HORMONE BINDING; HYPERGLYCEMIA; INFLAMMATION; MACROMOLECULE; MITOCHONDRION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN GLYCOSYLATION;

EID: 3042819615     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(04)94297-6     Document Type: Conference Paper

References (39)

1. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002; 5: 561-8.
2. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000; 47: 457-64.
3. Betteridge DJ. What is oxidative stress? Metabolism 2000; 49: 3-8.
4. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
5. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212.
6. Bonnefont-Rousselot D, Legrand A, Delattre J. The role of oxidative imbalance in diabetes mellitus in Redox Genome Interactions in Health and Disease. Fuchs J, Podda M, Packer L (Eds.). New York: Marcel Dekker, Inc.: 2003, chap. 23, 511-38.
7. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller M. Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-75.
8. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000; 23: 234-40.
9. Wierusz-Wysocka B, Wysocki H, Byks H, Zozulinska D, Wykretowicz A, Kamzmierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin pract 1995; 27: 193-7.
10. Vantyghem MC, Balduyck M, Zerimech F, Martin A, Douillard C, Bans S, Degand PM, Lefebvre J. oxidative markers in diabetic ketoacidosis. J Endocrinol Invest 2000; 23: 732-6.
11. Jain SK, McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 1999; 48: 1850-5.
12. Ruiz C, Alegria A, Barbera R, farre R, Lagarda MJ. Lipid, peroxidation band antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999; 59: 99-105.
13. 2α levels are elevated in individuals with NIDDM. FEBS Lett 1995; 368: 225-9.
14. 2α and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224-9.
15. Telci A, Catakay U, Kayali R, Erdogan C, Orhan Y, Sivas A, Akcay T. Oxidative protein damage in plams-aof type 2 diabetic patients. Horm Metab Res 2000; 32: 40-3.
16. Cakatay U, Telci A, Salman S, Salman L, Sivas A. Oxidative protein damage in type 1 diabetic patients with and without complications. Endocr Res 2000; 26: 365-79.
17. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicoreta T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-5.
18. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417: 150-2.
19. DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutr 2000; 130: 1509S-11S.
20. Navarro-Alarcon M, Lopez G, de la Serrana H, Perez-Valero V, Lopez-Martinez C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 1999; 228: 79-85.
21. Jain SK, Mc Vie R. Effect of glycemic control, race (white versus black) and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994; 43: 306-9.
22. Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, Russo A, Giacomello R, Stel G, Taboga C. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 1997; 20: 1589-93.
23. Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, Abdel-Aleem S. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999; 48: 1414-7.
24. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-90.
25. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
26. Jones RD, Hancock JT, Morice AH. NADPH oxidase: a universal sensor? Free Radic Biol Med 2000; 29: 416-24.
27. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-45.
28. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-95.
29. Singh R, Barden A, Mori T, Beilin L. Advanced glycation endproducts: a review. Diabetologia 2001; 44: 129-46.
30. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D. Advanced glycation end-products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-I) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-403.
31. Hamaoka R, Fujii J, Miyagawa J, Takahashi M, Kishimoto M, Moriwaki M, Yamamoto K, Kajimoto Y, Yamasaki Y, Hanafusa T, Matsuzawa Y, Taniguchi N. Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing a redox imbalance. J Biochem (Tokyo) 1999; 126: 41-7.
32. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49: 27-9.
33. Traverso N, Menini S, Cottalasso D, Odetti P, Marinari UM, Pronzato MA. Mutual interaction between glycation and oxidation during non-enzymatic protein modification. Biochim Biophys Acta 1997; 1336: 409-18.
34. Baynes J, Thorpe S. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
35. Bonnefont-Rousselot. Produits de glycation avancés: production et signification physiopathologique. Cah Nutr Diét 2003; 38: 122-9.
36. Schmidt AM, Hofmann M, Taguchi A, Yan SD, Stern DM. RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin Thromb Hemost 2000; 26: 485-93.
37. Bonnefont-Rousselot D. Thérapeutiques anti-oxydantes et anti-AGE: bilans et perspectives. J Soc Biol 2001; 195: 391-8.
38. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes Lancet 1998; 352: 854-65.
39. Bonnefont-Rousselot D, Raji B, Walrand S, Gardès-Albert M, Jore D, Legrand A, Peynet J, Vasson MP. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 2003; 52: 586-9.